Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sister chromatid cohesion protein PDS5 homolog A (PDS5A) is a large, highly conserved cohesin-associated scaffold protein that plays a central role in organizing chromatin architecture and ensuring proper chromosome segregation during both mitosis and meiosis[4]. In vertebrates, PDS5A and its paralog PDS5B are critical regulators of the cohesin complex, which mediates sister chromatid cohesion, DNA repair, gene transcription, and DNA replication[1][4]. PDS5A interacts directly with cohesin subunits, including RAD21, and recruits regulatory factors such as the acetyltransferase ESCO1 and the cohesin-release factor WAPL, modulating the stability, localization, and dynamics of cohesin on chromatin[4]. It is essential for establishing and maintaining chromatin loop boundaries, particularly at CTCF sites, and controls the length and stability of these loops—key factors in three-dimensional genome organization and gene regulation[2][3]. PDS5A also stabilizes cohesin’s association with chromatin by promoting SMC3 acetylation, which is necessary for accurate sister chromatid cohesion[2]. Beyond its canonical role in cohesion, PDS5A modulates DNA replication dynamics by regulating the residence time of cohesin at replication forks, facilitating their progression and recruiting replication fork protection factors[2]. In oocytes, PDS5A has a non-canonical role in meiotic spindle assembly, where it localizes to spindle microtubules and is required for proper spindle elongation and chromosome segregation, independent of its cohesin-related functions[5]. Structurally, PDS5A consists of over 1,300 amino acids, with two large HEAT repeat clusters separated by a helical insert domain; these repeats serve as scaffolds for multiple protein-protein interactions[1][5]. The N-terminus is highly conserved between PDS5A and PDS5B, while the C-terminus harbors paralog-specific features, including differential phosphorylation sites that may underlie their distinct and overlapping roles in cellular processes[4]. Mutations or dysregulation of PDS5A have been implicated in cancer and cohesinopathies, underscoring its importance in maintaining genome integrity and normal development[4]. Despite its critical functions, there are currently no known drugs that specifically target PDS5A, and its potential as a therapeutic target remains under investigation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sister chromatid cohesion protein PDS5 homolog A (PDS5A).